Story · Medicine & Biotech

Saad Usmani: ASH 2026 Highlights Emerging Immunotherapy Strategies in Multiple Myeloma

1 outlet · first reported by OncoDaily on

Saad Usmani, Chief of the Myeloma Service at Memorial Sloan Kettering Cancer Center and Professor of Clinical Medicine at Weill Cornell Medical College, shared on X: “The Best of ASH (OncoDaily)